Taking your project from bench to clinical studies

OUR SERVICES
 

GMP facilities for injectable and freeze-dried biological products

OUR SERVICES
 

Manufacture of small customized clinical batches

KNOW MORE
 

Biosafety level 3 (BSL-3) facility under GMP

MORE INFORMATION
 

Our own project to develop a vaccine against tuberculosis

RUTI® Project
1
1

Archivel Farma is a biotech company focused on innovative immunotherapeutic products.

Archivel Farma is specialized in the development of injectable and freeze-dried products.

Manufacturing

Process Development & Tech Transfer Scale-up & GMPs manufacturing

Facilities

Biosafety level 3 (BSL-3)
Class A/B cleanroom

Analytical QC & RD

Development, validation and testing analytical methods

Qualified Team

Personal trained
CXPs and biosafety standards

News

Archivel-Farma-renews-GMP-certification ArchivelPress release
20/01/2026

Archivel Farma renews GMP certification and strengthens its transformation into a CDMO

Archivel Farma announces that it has received the renewal of its GMP certification for manufacturing, confirming compliance with the requirements of the new Annex 1 to produce sterile and freeze-dried…
Albert Canals
0
Archivel-Farma-Joint-Efforts-in-Tuberculosis-Research Archivel
20/10/2025

RUTI® in combination with BCG Therapy Show Encouraging Outcomes in Bladder Cancer

Archivel Farma is delighted to anounce the outcome of RUTIVAC study in Bladder Cancer. The RUTI® vaccine, developed and produced in-house by Archivel Farma, was tested in a phase I…
Albert Canals
0
Archivel-Farma-Joint-Efforts-in-Tuberculosis-Research Archivel
02/08/2025

Joint Efforts in Tuberculosis Research: TB Alliance Visits Archivel

We were pleased to welcome Natalya Serbina, Senior Director at TB Alliance, to Archivel as part of our ongoing collaboration within the international Host Directed Therapy in Tuberculosis project. This…
Albert Canals
0